Care Property Invest NV

LSE:0R6H Stock Report

Market Cap: €461.6m

Care Property Invest Valuation

Is 0R6H undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0R6H when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0R6H (€12.5) is trading below our estimate of fair value (€37.73)

Significantly Below Fair Value: 0R6H is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0R6H?

Key metric: As 0R6H is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0R6H. This is calculated by dividing 0R6H's market cap by their current revenue.
What is 0R6H's PS Ratio?
PS Ratio6.6x
Sales€70.18m
Market Cap€461.62m

Price to Sales Ratio vs Peers

How does 0R6H's PS Ratio compare to its peers?

The above table shows the PS ratio for 0R6H vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average7x
ESP Empiric Student Property
7.2x8.5%UK£590.8m
SOHO Triple Point Social Housing REIT
5.9x4.1%UK£242.0m
HOME Home Reit
11.5xn/aUK£300.8m
RESI Residential Secure Income
3.3xn/aUK£104.1m
0R6H Care Property Invest
6.6x3.9%€461.6m

Price-To-Sales vs Peers: 0R6H is expensive based on its Price-To-Sales Ratio (6.6x) compared to the peer average (5.5x).


Price to Sales Ratio vs Industry

How does 0R6H's PS Ratio compare vs other companies in the European Residential REITs Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
0R6H 6.6xIndustry Avg. 8.8xNo. of Companies5PS0612182430+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0R6H is good value based on its Price-To-Sales Ratio (6.6x) compared to the European Residential REITs industry average (9.1x).


Price to Sales Ratio vs Fair Ratio

What is 0R6H's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0R6H PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.6x
Fair PS Ratio9.8x

Price-To-Sales vs Fair Ratio: 0R6H is good value based on its Price-To-Sales Ratio (6.6x) compared to the estimated Fair Price-To-Sales Ratio (9.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0R6H forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€12.50
€15.63
+25.0%
4.7%€16.50€14.50n/a4
Nov ’25€12.52
€15.50
+23.8%
4.6%€16.50€14.50n/a4
Oct ’25€14.40
€15.50
+7.6%
4.6%€16.50€14.50n/a4
Sep ’25€14.52
€15.50
+6.7%
4.6%€16.50€14.50n/a4
Aug ’25€13.96
€15.50
+11.0%
4.6%€16.50€14.50n/a4
Jul ’25€13.26
€15.50
+16.9%
4.6%€16.50€14.50n/a4
Jun ’25€13.98
€15.50
+10.9%
4.6%€16.50€14.50n/a4
May ’25€13.66
€15.13
+10.7%
2.7%€15.50€14.50n/a4
Apr ’25€12.86
€15.13
+17.6%
2.7%€15.50€14.50n/a4
Mar ’25€12.33
€15.25
+23.6%
1.6%€15.50€15.00n/a4
Feb ’25€13.10
€15.25
+16.4%
1.6%€15.50€15.00n/a4
Jan ’25€14.26
€15.13
+6.1%
4.9%€16.00€14.00n/a4
Dec ’24€12.98
€15.13
+16.5%
4.9%€16.00€14.00n/a4
Nov ’24€11.54
€15.38
+33.2%
2.7%€16.00€15.00€12.524
Oct ’24€11.88
€16.38
+37.8%
12.8%€20.00€15.00€14.404
Sep ’24€12.20
€16.88
+38.3%
12.3%€20.00€15.00€14.524
Aug ’24€12.72
€16.67
+31.0%
14.1%€20.00€15.00€13.963
Jul ’24€12.38
€19.00
+53.5%
15.5%€22.00€15.00€13.263
Jun ’24€12.52
€19.00
+51.8%
15.5%€22.00€15.00€13.983
May ’24€13.64
€19.50
+43.0%
23.1%€24.00€15.00€13.662
Apr ’24€12.74
€19.50
+53.1%
23.1%€24.00€15.00€12.862
Feb ’24€14.12
€29.50
+108.9%
18.6%€35.00€24.00€13.102
Jan ’24€15.76
€35.33
+124.2%
5.8%€38.00€33.00€14.263
Dec ’23€15.04
€34.63
+130.2%
6.2%€38.00€32.50€12.984
Nov ’23€16.68
€34.63
+107.6%
6.2%€38.00€32.50€11.544

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies